Mark T. Vander Lugt

ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death

Mark T. Vander Lugt, Thomas Braun, Samir Hanash et al. · New England Journal of Medicine · 2013 · 399 citations · Full text

Life Sciences, Hematology, Immunology +12

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery

Élie Haddad, Brent R. Logan, Linda M. Griffith et al. · Blood · 2018 · 175 citations · Full text

Life Sciences, Biomedical Sciences, Immunology +13

Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium

Monica S. Thakar, Brent R. Logan, Jennifer M. Puck et al. · The Lancet · 2023 · 113 citations · Full text

Medicine, Immunology, Pediatrics +10

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey

Alice Chan, Jennifer W. Leiding, Xuerong Liu et al. · Frontiers in Immunology · 2020 · 81 citations · Full text

Life Sciences, Hematology, Immunology +14

Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Subacute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation

Gregory A. Yanik, Shin Mineishi, John E. Levine et al. · Biology of Blood and Marrow Transplantation · 2011 · 65 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11